Skip to main content
. 2019 Aug 19;12:6623–6638. doi: 10.2147/OTT.S196630

Figure 5.

Figure 5

BMI1 was a direct target of miR-139-5p. (A) The relationship of miR-139-5p and BMI1 was predicted by starbase. (B and C) WT-BMI1 or MUT-BMI1 was cotransfected into Hep3B (B) and HepG2 (C) cells with miR-139-3p or their negative controls. (D and E) WT-BMI1 or MUT-BMI1 was cotransfected into Hep3B (D) and HepG2 (E) cells with miR-139-3p inhibitor or their negative controls. (F) BMI1 expression in HCC tissues. (G) BMI1 expression in LC-02, Hep3B, and HepG2 cells. (H) BMI1 expression under the condition of miR-139-5p overexpression in Hep3B and HepG2 cells. (I) BMI1 expression under the condition of SNHG3 overexpression in Hep3B and HepG2 cells. *P<0.05.

Abbreviations: HCC, hepatocellular carcinoma; SNHG3, small nucleolar RNA host gene 3.